GATA4 and GATA6 are zinc-finger transcription factors that regulate specific genes involved in steroidogenesis. Using RNA interference (RNAi)-mediated reduction of GATA4 and/or GATA6 with microarray analysis, we aimed to identify novel GATA target genes in luteinizing porcine granulosa cells under vehicle-and cAMP-treated conditions. Microarray analysis identified IGF1 mRNA to be cAMP-and GATA-responsive, and real-time PCR demonstrated that the cAMP-induced increase in IGF1 mRNA was reduced under conditions of GATA6 depletion and GATA4 plus GATA6 depletion, but not GATA4 depletion. Insulin-like growth factor 1 protein levels in media were also decreased by GATA6 or GATA4 plus GATA6 reduction. IGFBP2 and IGFBP4 mRNAs were increased and IGFBP5 mRNA decreased with vehicle and cAMP treatment under GATA4 plus GATA6 RNAi conditions. GATA6 reduction alone increased basal IGFBP4 and decreased IGFBP5 with both vehicle and cAMP, and GATA4 reduction alone lowered cAMP IGFBP5 levels with cAMP. No changes in IGFBP3 mRNA were observed with GATA reduction relative to the control RNAi condition. Levels of insulin-like growth factor binding proteins 2-5 in media as assessed by Western ligand blotting were not altered by GATA reduction. Electromobility gel shift assays with two GATA-containing oligonucleotides of the IGF1 5 0 -regulatory region showed GATA4 and GATA6 could bind the more proximal GATA-B site. These studies indicate that although GATA4 and GATA6 can bind the porcine IGF1 5 0 -region, GATA6 is functionally most important for cAMP-stimulated mRNA levels. Using microarray analysis, we identified other mRNAs that were altered by GATA-reduced conditions, including ALDH1, DIO2, and EDNRB. Our findings further support GATA as a coordinator of endocrine/paracrine/autocrine signals in the ovary.
INTRODUCTION
Both GATA4 and GATA6 are members of the GATA family of zinc-finger transcription factors that recognize the consensus DNA element (A/T)GATA(A/G) [1] . They are expressed in the adult endocrine tissues, including testes and ovaries [2, 3] . The maturing follicles of the adult ovary exclusively express GATA4 and GATA6 [3] . One or both of these factors can regulate genes important to ovarian function, including several genes mediating the production of steroids (e.g., Star, Cyp11a1, and Cyp19a1), the inhibin alpha subunit (Inha), anti-Müllerian hormone (Amh), Bcl2, and cyclin D2 (Ccnd2) [2] , but few other ovarian GATA targets are known. The functional importance of GATA to ovarian steroidogenesis is supported by the finding that theca cells from patients with polycystic ovarian syndrome (PCOS) have elevated GATA6 expression in combination with higher steroidogenic gene expression and higher androgen production [4] .
The levels of ovarian GATA4 and GATA6 vary during the estrous cycle in a species-specific manner [5] [6] [7] [8] [9] . GATA4 levels tend to be lower in the corpus luteum compared to follicles, whereas GATA6 is strongly expressed in the corpus luteum [5] [6] [7] [8] [9] . Using an RNA interference (RNAi) knockdown approach in primary cultures of luteinizing porcine granulosa cells, we previously demonstrated that the relative amounts of GATA4 and GATA6 altered the expression of steroidogenic acute regulatory protein (STAR) mRNA and progesterone production without major impacts on cAMP-stimulated CYP11A1 or HSD3B mRNA levels [10] . The reduction of GATA4 in cells increased cAMP-mediated STAR mRNA levels, but not when GATA6 was also reduced. These studies suggested that GATA4 and GATA6 are able to recognize the same gene targets but may exert different actions in the native context of the cell.
Insulin-like growth factor 1 (IGF1) is required for normal ovarian function [11] . Mice null for the Igf1 gene have arrested follicular development, do not ovulate or form corpora lutea, and are infertile [12] . In the pig, both liver and ovarian sources of IGF1 impact reproductive efficiency and play a role in both follicular and luteal function [13, 14] . Porcine ovarian IGF1 is a product of theca externa, granulosa, and luteal cells [15] [16] [17] [18] and has been shown to stimulate [19, 20] or amplify [21, 22] gonadotropin-stimulated steroidogenic endpoints. IGF1 promotes granulosa cell survival [23] . In addition, IGF1 infusion into the ovarian vasculature can transiently increase luteal progesterone production in pigs [20] . Insulin-like growth factor binding proteins (IGFBPs), which regulate IGF1 availability, are also abundant in follicles and corpora lutea and are produced by ovarian somatic cells [17, [24] [25] [26] . Gonadotropins, protein kinase A pathway agonists, and growth hormone have been shown to stimulate the mRNA for IGF1 in porcine granulosa cells [16] . Studies in extrahepatic tissues, such as granulosa cells, indicate that IGF1 mRNAs derive from multiple transcriptional start sites [16, 27, 28] and that transcripts utilize different promoters including regions of exon 1 or exon 2 [29] [30] [31] . Despite the critical importance of local IGF1 to follicular and luteal function, ovarian-specific transcriptional regulation of its gene has been elusive, most likely because of the gene's complexity.
In the present study, we initially aimed to identify novel gene targets and possible functions of GATA4 and GATA6 in granulosa cells undergoing terminal differentiation by coupling RNAi-mediated depletion of these GATA factors with microarray analyses. The microarray studies identified IGF1 to be the most highly cAMP-induced mRNA in our model and a likely GATA target. Messenger RNAs encoding IGFBPs 2 and 5 were also found to be altered under specific GATA reduced conditions as assessed by microarray analysis. Given the critical importance of intraovarian IGF1 to pig reproduction and the lack of information regarding transcriptional regulation of the IGF1 gene in the ovary, our microarray findings led us to test the hypothesis that one or both of these GATA factors regulate the amount of available IGF1 made by luteinizing granulosa cells. The main purpose of the present study was to evaluate the impact of reducing GATA4 and GATA6 factors on IGF1 and IGFBP mRNA and protein levels and to determine if GATA factors may affect IGF1 availability during luteinization.
MATERIALS AND METHODS

Materials
General chemicals were obtained from Sigma and Fisher Scientific. Cell culture reagents, Lipofectamine 2000, Trizol, and all synthesized oligonucleotides were purchased from Invitrogen Corp. HALT protease and phosphatase inhibitor cocktails were purchased from Pierce Biotechnology. Cell culture plates were obtained from Falcon. Abattoir ovaries from prepubertal gilts were purchased from Greenwood Packing Plant, Inc.
GATA RNAi and Transfection of Porcine Granulosa Cells
Granulosa cells were isolated from 1-to 5-mm ovarian follicles of prepubertal gilts by needle aspiration as previously described [32] . Cells were plated in complete medium consisting of minimal essential media (MEM) containing 3% fetal calf serum and antibiotics (2.5 lg/ml of amphotericin B, 50 U/ml of nystatin, 10 U/ml of penicillin, 10 lg/ml of streptomycin, and 100 lg/ ml of gentamicin) at a density of 8 3 10
6 live cells/well in six-well culture plates. GATA4 and GATA6 depletion in granulosa cells was performed using validated GATA Stealth RNAi molecules synthesized by Invitrogen as previously described [10] . After 40-42 h of culture, cells were rinsed with serum-free MEM without antibiotics and transfected with 200 nM RNAi using 5 ll of Lipofectamine 2000 for 24 h. The control transfection consisted of 200 nM firefly luciferase RNAi. GATA4 transfection consisted of 100 nM GATA RNAi plus 100 nM firefly luciferase RNAi, and GATA6 transfection consisted of 100 nM GATA6 RNAi plus 100 nM firefly luciferase RNAi. The combined GATA4 plus GATA6 transfection consisted of 100 nM GATA4 plus 100 nM GATA6 RNAi. After transfection, medium was replaced with complete medium, and cells were incubated for 72 h before treatment. Granulosa cells were treated (time ¼ 0 h) in serum-free medium containing antibiotics with vehicle (sterile water) or the cAMP analog 8-bromoadenosine 3 0 ,5 0 -cAMP (8Br-cAMP; 1 mM; Sigma) for various times up to 24 h. GATA reduction was verified by real-time PCR and/or Western blotting as previously described and was typically greater than 60% [10] .
RNA Isolation and Real-Time PCR
Total RNA was extracted from granulosa cells using Trizol reagent and was subjected to DNase I treatment using the RNeasy Micro kit (Qiagen, Inc.). RNA was quantified spectrophotometrically. The cDNA was synthesized using Taqman Reverse Transcription Reagents (Applied Biosystems).
Real-time PCR was carried out using 20 ng of cDNA, specific primer sets, and SYBR Green Master Mix (Applied Biosystems) with 10 nM fluorescein using a iCycler iQ Real-Time PCR Detection System (Bio-Rad Laboratories, Inc.). Primer sets and their specific reaction conditions are listed in Table 1 . Amplification efficiencies were determined for all primer sets. Relative quantification using RPS16 mRNA as an internal control was performed according to method of Pfaffl as previously described [33, 34] . Amplicons were verified by the presence of single peaks on melt curves and by visualization of correct-sized products on agarose gels. Amplicons of newly designed primer sets not previously reported were verified by amplification of products without SYBR green followed by direct DNA sequencing (Genewiz, Inc.).
Microarray Analyses
Microarray analysis was performed with granulosa cell RNA from five treatment groups, including the vehicle-treated control RNAi condition, 8Br-cAMP-treated control, and the GATA4, GATA6, and GATA4 plus GATA6 RNAi conditions. Two independent RNA sets for the five treatments were prepared for microarray hybridization. The first set consisted of equal amounts of RNA per treatment pooled from three separate experiments. A second set of RNA for hybridization originated from a larger, fourth experiment. RNA integrity was confirmed using a 2100 Bioanalyzer (Agilent). The cRNA preparation from 5 lg of total RNA and hybridization to Affymetrix GeneChip Porcine microarrays (catalog no. 900623) were performed at the Medical University of South Carolina (MUSC) Proteogenomics Facility (Charleston, SC) in accordance with standardized Affymetrix protocols as previously described [35] [36] [37] . Hybridized microarrays were scanned with a GeneChip Scanner 7G. Microarray files (individual lArrayDB) of this project can be accessed online (http://proteogenomics.musc.edu/ma/musc_madb. php?page¼home&act¼manage under the cRNA target record numbers _1211218721.948306 and _1221662238.594980). Resulting hybridization signals (.CEL files) were normalized by Robust Multichip Algorithm [38] using the WebArray 1.3 utility [39] . Pairwise comparisons of normalized data were performed for the 8Br-cAMP treatment versus vehicle treatment under control RNAi conditions using dChip software [40] . Similar comparisons were also performed for all 8Br-cAMP-treated RNAi conditions versus the control RNAi condition. Candidate differentially expressed genes were identified by the criteria of expression change greater than 1.5-fold and paired t-test (P , 0.05). Annotation of Affymetrix probe sets was made by subjecting the GenBank reference sequence to the National Center for Biotechnology Information BLASTN algorithm; the known gene sequence with the highest percentage match and coverage was used for annotation.
Western Ligand Blots
Medium was collected from wells at the end of culture, and 4 ml of conditioned medium were spun at 1900 3 g (3000 rpm) in a Sorvall 6000T with swinging bucket rotor for 20 min at 48C to remove debris. Cleared media were concentrated at the same speed by an average of 16-fold using Amicon Ultra Centrifugal Filters (3-kDa molecular weight cut off [MWCO]) at 48C. Western ligand blots were performed as previously described with minor modifications [19, 25, 26] . Aliquots of concentrated medium were combined with loading buffer, heated for 3 min at 1008C, spun briefly, and resolved under nonreducing conditions on 10% SDS-polyacrylamide gels. Proteins were transferred to nitrocellulose membranes and stained with Ponceau S to assess transfer. After destaining in water, membranes were washed for 30 min with PBS containing 0.1% Tween-20 (PBS-T), then blocked for 2 h at room temperature in PBS-T containing 1% bovine serum albumin (BSA). Each membrane was incubated overnight at 48C in PBS-T, 1% BSA, and [ 125 I]IGF1 (400 000 cpm per 10 ml of buffer; Perkin-Elmer), followed by five washes in PBS-T. The air-dried membranes were exposed to BioMax MR film (Kodak) using a BioMax MS intensifying screen (Kodak) at À808C. Densitometric analyses of autoradiographic bands were performed using UN-SCAN-IT gel version 5.1 software (Silk Scientific). Each band was corrected for the concentration factor for the medium, then normalized to the DNA content of the wells.
IGF1 ELISA and DNA Measurements
Media were collected from wells at the end of the 24-h treatment period and debris pelleted as above. Four milliliters of conditioned medium were concentrated approximately 34-fold using Amicon Ultra Centrifugal Filters (3-kDa MWCO) as described above but with spinning for longer duration. Free and easily dissociated IGF1 in concentrated media was measured in duplicate using the Quantikine Human IGF1 ELISA (DG100; R&D Systems) as recommended for cell culture supernatants, because mature human and pig IGF1 are identical. Recombinant human IGF1 standards were prepared in serum-free MEM. The mean minimum detectable dose for the assay was 0.026 ng/ml. The intra-and interassay coefficients of variation were 4.0% and 8.0%, respectively. The measured concentrations were corrected for the concentration factor and normalized for the DNA content of wells.
Total DNA content per well was measured by Hoechst dye method using the DNA Quantification Kit Fluorescence Assay (Sigma) [41] . Cells were scraped in 13 assay buffer and frozen at À808C. Cells were sonicated briefly on ice before assay [10] .
Nuclear Protein Isolation and Electromobility Gel Shift Assay
Granulosa cell nuclear protein isolation was performed at the end of the treatment for 2, 6, or 24 h using the hypotonic lysis method as previously described [10, 42] . Protein was quantified using Bio-Rad Dye reagent. The final concentrations within the DNA binding reaction used for electromobility gel shift assay (EMSA) were 5% glycerol, 0.5 mM dithiothreitol, 100 mM KCl, 10 mM Tris (pH 7.5), 12.5 mM Hepes, 2 lg of poly dI-dC (Sigma), 0.25 mM ethylenediaminetetra-acetic acid (EDTA), 0.025% HALT protease inhibitor, and 0.025% phosphatase inhibitor. Double-stranded oligonucleotides were end labeled using T 4 polynucleotide kinase (Promega) and c-[
32 P]ATP (PerkinElmer). For supershift and competition assays, nuclear extracts (3-8 lg) were preincubated with antibodies (1.5-6 lg) or 100-fold excess cold competitor oligonucleotides for 30 min on ice before addition of 100 000 cpm of highspecific-activity oligonucleotide. Reactions were further incubated on ice for 30 min and electrophoresed on 4.5% native polyacrylamide gels with 0.53 Trisborate-EDTA buffer for 2.5 h at 150 V. After drying, bands were visualized by autoradiography using BioMax MR film. Antibodies used for gel shift assays were GATA4 sc-1237X, GATA6 sc-7245X, and normal goat immunoglobulin (Ig) G (Santa Cruz). The Sp1, AP-1, and TFIID consensus oligonucleotides were purchased from Promega. Oligonucleotides corresponding to sequences within exon 1 of the porcine IGF1 gene containing the putative GATA rat sites GATA-A (þ108) and GATA-B (þ183) [30] were generated by annealing sense and antisense strands for the following sequences: GATA-A, 5
0 -GTTTTGTA-GATAAATGTGAG-3 0 ; GATA-B, 5 0 -TCAGAGCAGATAGAGCCTGC-3 0 . The GATA-2X oligonucleotide sequence was generated by annealing sense and antisense strands for 5 0 -CACTTGATAACAGAAAGTGATAACTCT-3 0 .
Data Analyses
The RNA, ligand binding, and ELISA data were analyzed by one-way repeated-measures ANOVA followed by Tukey post-hoc test. Fold-changes under basal conditions and cAMP-stimulated conditions were also analyzed in separate ANOVAs. Comparison of vehicle with 8Br-cAMP data for each RNAi was performed by paired one-tailed t-test. Statistical significance was considered to be P 0.05. Statistical comparisons were performed using GraphPad Prism version 3.02 for Windows (GraphPad Software).
RESULTS
Microarray Reveals Potential GATA Target Genes, Including IGF1
Total RNA from five treatment groups (n ¼ 2) was subjected to microarray analyses using the Affymetrix Porcine Genome Array, which contains 23 937 probe sets for an estimated coverage of 20 201 genes. By our preset differential expression criteria, 160 genes showed significant regulation by cAMP analog (96 increased, 64 decreased) ( Table 2 and not shown). In samples receiving cAMP treatment, GATA4 RNAi conditions resulted in seven genes (seven probe sets) significantly changed, GATA6 RNAi conditions resulted in 16 genes (18 probe sets) changed, and GATA4 plus GATA6 RNAi conditions resulted in 50 genes (55 probe sets) with significant regulation. The majority of changes meeting our significance criteria involving GATA were observed for the GATA4 plus GATA6 coreduced condition treated with 8Br-cAMP ( Table 2) . IGF1 was the most highly stimulated cAMPresponsive mRNA under control RNAi conditions and was significantly decreased by GATA4 plus GATA6 RNAimediated depletion. IGF1 mRNA also exhibited consistently lower hybridization signals with GATA6 knockdown alone, although these did not reach significance by our preset criteria (Table 2) . Consistent trends for IGF1 were observed with four different probe sets on the array. By array, IGFBP2 mRNA was found to be increased with GATA4 plus GATA6 coknockdown, and IGFBP5 mRNA was decreased by coknockdown. The relative expression profiles of IGF1, IGFBP2, and IGFBP5 mRNAs from the microarray are shown in Supplemental Figure S1 (available online at www.biolreprod. org). 
GATA REDUCTION IMPACTS IGF1 AVAILABILITY
Verification of Select Microarray Data by Real-Time PCR
Six other genes-ALDH1, GJA1, DIO2, EDNRB, MMP1, and NR5A2-were selected from the microarray data for further analyses by real-time PCR to verify their microarray results (Fig. 1) . By microarray and real-time PCR, ALDH1 mRNA, which encodes a retinaldehyde dehydrogenase isoform, was significantly increased by cAMP analog. No GATA reduction condition significantly altered the basal or cAMP effect relative to control RNAi. However, ALDH1 mRNA stimulation by cAMP was lost under GATA4 RNAi conditions, and GATA4 RNAi conditions lowered the vehicle and cAMP treatment responses relative to GATA6 RNAi (P , 0.05). By microarray, the GATA6 and the GATA4 plus GATA6 RNAi conditions enhanced levels of DIO2 mRNA, which encodes deiodinase type 2, but by real-time PCR, significant increases were restricted to the GATA4 plus GATA6 RNAi condition. Furthermore, a significant stimulation of DIO2 mRNA by cAMP treatment was detected by realtime PCR but not by microarray. EDNRB, which encodes endothelin receptor B, was not regulated by cAMP, yet GATA4 plus GATA6 coreduction increased its expression with cAMP treatment as measured by both microarray and PCR. Under the same conditions, mRNA for EDN1, which codes for the ligand of EDNRB, was not affected by GATA reduction (n ¼ 3, not shown). Levels of GJA1 mRNA, which encodes connexin 43, by real-time PCR varied from the microarray in that its expression with GATA coreduction was significantly increased with cAMP and that individual GATA RNAi effects observed by microarray were not reproduced over several experiments using real-time PCR. MMP1 mRNA, which encodes matrix metalloproteinase 1, was increased by cAMP analog treatment, but the GATA effect observed by microarray was not reproduced in PCR studies, indicating it is not a GATA target. Levels of NR5A2 mRNA, which encodes transcription factor nuclear receptor family 5 member A2, were increased significantly by cAMP as determined by real-time PCR and by microarray. GATA4 plus GATA6 coreduction increased NR5A2 mRNA levels as assessed by real-time PCR, an effect that was not observed by microarray. PCR Verifies IGF1 and Specific IGFBP mRNAs Are Altered with GATA Reduction
Real-time PCR was utilized to examine the expression of IGF1 mRNA in all treatment groups (Fig. 2) . IGF1 mRNA was stimulated by cAMP analog under all RNAi conditions (P , 0.005); however, both the GATA6 and the GATA4 plus GATA6 RNAi conditions significantly reduced the amplitude of the cAMP effect by 35-40% compared to control RNAi with vehicle (n ¼ 8, P , 0.01). Basal (vehicle treatment) IGF1 mRNA expression was also reduced by combined GATA4 plus GATA6 reduction (P , 0.05). GATA4 reduction alone did not affect IGF1 mRNA levels.
We next evaluated mRNAs encoding IGFBP2 and IGFBP5, which exhibited detectable changes by microarray, and mRNAs encoding IGFBP3 and IGFBP4, which are also made within the porcine ovary [15, 17] (Fig. 2) . Under control RNAi conditions, 24-h treatment with 8Br-cAMP increased IGFBP2 and IGFBP4 mRNA (P , 0.05), decreased IGFBP5 mRNA (P , 0.05), and did not affect IGFBP3 mRNA (n ¼ 6). GATA4 reduction alone with 8Br-cAMP decreased IGFBP5 mRNA compared to control RNAi (P , 0.05). GATA6 reduction also led to increased basal expression of IGFBP4 and decreased levels of IGFBP5 with basal and 8Br-cAMP treatments (P , 0.05). GATA4 plus GATA6 coreduction increased basal and cAMP-stimulated IGFBP2 and IGFBP4 mRNA levels and decreased mRNA for IGFBP5 (P , 0.05).
IGFBP Ligand Binding Is Not Affected by GATA Reduction
To determine whether alterations in IGFBP mRNAs resulting from GATA reduction altered the IGFBP ligand binding capacity in the media, Western ligand blotting was performed using media collected and concentrated at the end of the treatment period (Fig. 3) . The five IGFBP bands reported for pig ovary of molecular masses of approximately 44, 40, 34, 30 , and 24 kDa were present [19, 24, 43] . The 40/44-kDa bands have been reported to correspond to IGFBP3, the 34-kDa band to IGFBP2, the 30-kDa band to IGFBP5 and glycosylated IGFBP4, and the 24-kDa band to IGFBP4 [19, 24, 26, [43] [44] [45] . In contrast to effects on IGFBP mRNAs, IGF1 binding capacity of proteins with molecular masses corresponding to IGFBPs 2-5 in concentrated media did not show differences with GATA reduction. Under control RNAi conditions, 8Br-cAMP treatment increased the amount of the IGFBP4-containing bands (24 and 30 kDa). Although means were numerically elevated for the 24-and 30-kDa bands with cAMP treatment only, the 30-kDa band exhibited a significant effect with a GATA reduced condition (i.e., GATA6 RNAi).
FIG. 1. Real-time PCR verification of microarray data for select mRNAs. The labels C, G4, G6, and G4þG6 represent the control, GATA4, GATA6, and combined GATA4 plus GATA6 RNAi condition, respectively. Treatments (vehicle or 8Br-cAMP, 24 h) and statistical analyses are as described in Materials and Methods. Bars represent the mean 6 SEM (n ¼ 4 independent experiments for GJA1 and MMP, 5 independent experiments for ALDH1, and 6 independent experiments for DIO2, EDNRB, and NR5A2). An asterisk indicates that the treatment with 8Br-cAMP is significantly higher than the vehicle treatment with the same RNAi; the letter a indicates the vehicle treatment for the RNAi is significantly different from that of the control RNAi; the letter b indicates the 8Br-cAMP treatment for the RNAi is significantly different from the control RNAi; and the letter c indicates the fold-response to 8Br-cAMP for the RNAi differs from the foldresponse to 8Br-cAMP for the control RNAi (P , 0.05 for all). A plus symbol indicates the comparison of vehicle to 8Br-cAMP treatment for GJA1 under the Control RNAi condition approached significance (P , 0.06).
Free and Easily Dissociated IGF1 in Media Is Decreased by GATA6 and by GATA4 Plus GATA6 Reduction Free and easily dissociated IGF1 in concentrated culture medium collected at the end of the 24-h treatment was assayed by ELISA. Values were corrected for concentration factor and normalized for DNA content of wells (Fig. 4) . Cyclic AMP analog increased IGF1 levels in media that were decreased under GATA6 and GATA4 plus GATA6 knockdown conditions (n ¼ 3, P , 0.05).
EMSAs Indicate Both GATA4 and GATA6 Can Bind to the IGF1 Gene GATA-B Site
Because exon 1 of the IGF1 gene of other species has been shown to promote transactivation in certain cellular settings, we tested the ability of the two GATA consensus sequences, denoted GATA-A and GATA-B, within this region to form protein-DNA complexes with treated granulosa cell nuclear extracts by EMSA. Both IGF1 gene oligonucleotides formed protein-DNA complexes under all RNAi and treatment conditions at 2 h of treatment (Fig. 5A) and at 6 and 24 h of treatment (not shown). Decrements in the intensity of protein-DNA complexes were observed with the GATA-B oligo with GATA reduction, with the lowest-intensity complexes being observed with GATA4 plus GATA6 coreduction (Fig. 5A) . No difference in GATA-B complex intensity was observed with 8Br-cAMP treatment. The GATA-A oligo formed an intense complex with nuclear extracts but showed no trend with GATA reduction or treatment (Fig. 5A, bottom) . The GATA-B oligonucleotide was competed by excess cold self oligo and an oligo containing two GATA consensus sites (Fig. 5B) , whereas the GATA-A oligo complex was only competed by cold self oligo and not by the GATA-consensus oligo. These data indicate that GATA molecules can bind the GATA-B site, but not the GATA-A site, in granulosa cell extracts. The proteins binding the GATA-A oligo were not identified and were not competed by 100-fold excess of cold oligos for Sp1, AP-1, or TFIID (not shown). Supershift assays with goat anti-GATA6 and goat anti-GATA4 were both able to reduce or supershift protein-DNA complexes under all RNAi conditions and treatments (Fig. 5C and not shown) and also indicated   FIG. 2. GATA6 and the GATA4 plus GATA6 coreduction decrease IGF1 mRNA levels, and IGFBP mRNAs show various responses to GATA reduction as measured by real-time PCR. Granulosa cells under control or GATA-reduced conditions were treated with either vehicle or 8Br-cAMP (1 mM) for 24 h. The ratios of each target mRNA to RPS16 mRNA were normalized to the control RNAi condition with vehicle treatment. Axis labels are as in Figure 1 . Bars represent the mean 6 SEM (n ¼ 8 independent experiments for IGF1 and 6 independent experiments for IGFBPs). An asterisk indicates that treatment with 8Br-cAMP was significantly different from vehicle under the same RNAi condition (P , 0.05); the letter a indicates vehicle treatment differs significantly from the control RNAi vehicle treatment (P , 0.05); and the letter b indicates 8Br-cAMP treatment differs significantly from control RNAi 8Br-cAMP treatment (P , 0.05 for all).
residual GATA4 or GATA6 binding under each GATA RNAi condition. Interestingly, the intensity of the supershifted bands with the GATA4 antibody was reduced under conditions of GATA6 reduction, suggesting that GATA4 may interact with GATA6 at this oligo or that the GATA4 antibody may crossreact with GATA6.
DISCUSSION
Our goal to identify novel GATA4 and GATA6 target genes in luteinizing granulosa cells by microarray analysis following RNAi-mediated GATA reduction was successful, and we identified IGF1, IGFBP2, and IGFBP5 as potential GATAregulated genes. Because IGF1 is an important autocrine/ paracrine factor within the pig ovary, playing an essential role in steroidogenic responses of the follicle and corpus luteum [13, 14] , we selected it for further study. IGFBPs regulate availability and stability of IGFs; thus, we further examined the mRNAs identified from the microarray analysis and those encoding IGFBP3 and IGFBP4 known to be secreted by porcine granulosa and luteal cells [17, 19, 24, 43] . We did not evaluate mRNAs for IGFBP1 and IGFBP6, because they have been reported to be undetectable in porcine granulosa [43] and IGFBP1 signals were undetectable by microarray (not shown).
IGF1R expression by microarray was not altered by cAMP treatment or GATA reduction (not shown), so we did not evaluate it further. Real-time PCR confirmed some of the trends found with microarray analysis for IGF1, IGFBP2, and IGFBP5 and also revealed additional significant changes. For example, by real-time PCR, GATA6 reduction alone and GATA4 plus GATA6 coreduction were able to decrease the levels of IGF1 mRNA in response to cAMP analog, indicating GATA6 is the major GATA that regulates IGF1 expression. In addition, under control RNAi conditions, IGFBP2 mRNA was significantly increased by, and IGFBP5 mRNA decreased by, treatment with cAMP analog. The additional findings most likely resulted from the greater sensitivity of real-time PCR compared to microarray [46] and to the increased number of experiments used for PCR analysis. No probe sets for IGFBP4 were identified on the microarray. However, real-time PCR showed an increase in IGFBP4 mRNA with GATA4 plus GATA6 coreduction with both vehicle and 8Br-cAMP treatment, and GATA6 reduction alone increased basal expression. Microarray analysis did not detect significant alteration in IGFBP3 mRNA, and this result was fairly consistent with real-time PCR data, with the exception that cAMP effects reached statistical significance under all GATA RNAi conditions. The levels of free and easily dissociated IGF1 in concentrated media followed a pattern similar to that of the IGF1 mRNA, with GATA6 and GATA4 plus GATA6 RNAi conditions reducing the cAMP stimulation of IGF1. Therefore, the changes observed for IGFBP mRNAs may be a response to the alterations in IGF1 levels in the media. Addition of IGF1 to granulosa cell cultures has been shown to decrease IGFBP2 mRNA in bovine [47] and to increase IGFBP5 mRNA in rat and pig [43, 48] ; thus, an opposite response to IGF1 reduction might be expected. In previous reports, IGF1 did not increase IGFBP4 mRNA, although follicle-stimulating hormone (FSH) did in primary granulosa cells [43, 44] . IGF1 either stimulated or had no effect on IGFBP3 mRNA levels in granulosa cells [44, 49] and was regulated by FSH in a biphasic manner [50] . Despite the findings that some IGFBP mRNAs were altered by specific GATA RNAi conditions, IGFBP binding of [
125 I]IGF1 in Western ligand blots was not altered by GATA reduction, indicating that RNAi conditions did not affect steady-state IGFBP levels. Such uncoupling of IGFBP mRNA and protein levels was previously observed in a porcine granulosa cell line where IGF1 differentially affected the mRNA and protein levels of some IGFBPs [44] . Other reasons for differences between the IGFBP mRNAs and their protein levels may result both from the lower sensitivity of the ligand blots to detect small changes in IGFBPs compared to real-time PCR and from the time point evaluated.
In some instances, it is possible that GATA influences on IGFBP genes may be direct. We reviewed the 5 0 -flanking regions for the relevant IGFBP genes available in GenBank for potential GATA sites (not shown). Our in silico analyses of the porcine IGFBP2 gene 5 0 -flanking region (GenBank accession no. U21117.1) revealed at least two uncharacterized GATA consensus sequences within the first 1100 bp. Because the pig sequence is not yet accessible, we also examined approximately 1900 bp of the 5 0 -flanking region of the human IGFBP5 gene (GenBank accession no. AY534685.1) and identified three GATA consensus sequences. In contrast, analyses of the first 2500 bp of the human IGFBP4 gene 5 0 -flanking region (GenBank accession no. AC018629.12) revealed no GATA consensus sites. Whether the identified GATA consensus sequences in the IGFBP2 and IGFBP5 genes are functional remains to be experimentally determined.
Transcriptional activation of the IGF1 gene is complex. Exon 1 (class 1)-and exon 2 (class 2)-led transcripts are generated through the use of different promoters [31, [51] [52] [53] . The predominance of one transcript class over the other is tissue dependent [28, 54] . Even within classes, there can be more than one transcriptional start site [51, 55] . Porcine granulosa cells have been shown to increase IGF1 mRNA in response to growth hormone, FSH, or activators of protein kinase A [16] . In addition, class 1 transcripts predominate over class 2 transcripts in these cells [16] , suggesting that the exon 1 promoter region is more active or that class 1 transcripts are more stable. To further test whether the IGF1 gene could be a direct target for GATAs, we performed EMSAs to analyze GATA sequences located within exon 1 previously reported by Wang et al. [30] . Using neuroblastoma cells, those authors found that mutation of the GATA-B site in the context of the þ75-to þ192-bp region of the rat Igf1 exon 1 reduced basal reporter gene activity, whereas a GATA-A site mutation increased basal activity. Although the authors showed by competition that a GATA-like molecule could bind to the A and B sites, supershift studies with antibodies to GATAs 1-4 failed to reveal the identity of the proteins in complexes. Our current study shares similarities to this previous study in that cold GATA consensus oligonucleotide was able to compete proteins off the GATA-B site, but the present study differs in that it was unable to effectively compete complexes with the GATA-A oligo. In addition, we demonstrated by antibody experiments that GATA4 and GATA6 in granulosa cell nuclear extracts could bind the GATA-B oligo. Based on band patterns with antibodies, we cannot rule out that an interaction between GATA4 and GATA6 exists at the GATA-B site. After extensive attempts, we have not been able to detect differences between control IgG and the GATA antibodies utilizing chromatin immunoprecipitation (ChIP) assays of the porcine IGF1 exon 1 region or the porcine STAR promoter used as a positive control (not shown). However, antibodies for acetylated-histone 3 and CEBPB (a C/EBP site is adjacent to the GATA-B site [56] ) were effective at precipitating both promoters in the same lysates (not shown). Previous work in bovine corpus luteum [57] using the GATA6 antibody also failed to precipitate the bovine STAR promoter, suggesting the antisera may not be suitable for ChIP in bovine and pig. When all our studies are considered together, the results indicate that IGF1 is a potential GATA4 and GATA6 binding target but that GATA6 is functionally most important for IGF1 mRNA levels.
In addition to IGF1, several of the regulated genes identified by microarray, such as ALDH1, DIO2, and ENDRB, participate in endocrine, paracrine, or autocrine signaling in the ovary. The products of these genes participate in retinoic acid synthesis [58] , thryoxine conversion to triiodothyronine (T 3 ) [59] , and endothelin action. In the human, one or more GATA consensus sequences have been identified in the 5 0 -flanking regions for each of these three genes [59] [60] [61] [62] . In our PCR studies, GATA4 reduction led to loss of cAMP-responsiveness for ALDH1, but control levels were restored by coreduction of GATA6, indicating that the relative levels of the two GATA factors may affect ALDH1 mRNA expression but that neither factor is required for its expression. In contrast, DIO2 and ENDRB FIG. 4 . Stimulated IGF1 levels in culture medium are reduced by granulosa cell GATA6 and GATA4 plus GATA6 depletion. An asterisk indicates that treatment with 8Br-cAMP was significantly different from vehicle under the same RNAi condition (P , 0.03), and the letters a and b indicate the 8Br-cAMP treatment was significantly different from control RNAi 8Br-cAMP treatment (P , 0.05 and P , 0.01, respectively). mRNAs were significantly increased by combined GATA4 plus GATA6 reduction under cAMP conditions, indicating both GATA factors may control T 3 availability and cellular sensitivity to endothelin.
Overall, the findings are consistent with GATA4 and GATA6 having partially redundant functions. First, using microarray analysis, it was observed that the number of genes affected by combined GATA4 plus GATA6 coreduction was greater than that affected by reduction of either GATA factor alone. Additionally, the microarray and PCR results showed that in a few cases, GATA4 or GATA6 reduction alone could cause changes in the same genes. Nevertheless, in some cases, such as IGF1, one GATA factor (i.e., GATA6) played a dominant role in affecting regulation, and in many other instances, a gene was affected by only one of the GATA factors. Therefore, GATA4 and GATA6 can play distinct roles as well. Interactions between retinoic acid, thyroid hormone, and IGFBP regulation have been reported in hepatocytes [63] , and these interactions may also be occurring in our cell model. GATA RNAi-driven changes in IGF1 may also be influencing some of the other mRNA expressions. Taken together, these studies further support GATA as a coordinator of endocrine/ paracrine/autocrine signaling in the ovary.
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FIG. 5. EMSA shows that GATA-B, but not GATA-A, oligonucleotides corresponding to the porcine IGF1 exon 1 can bind GATA4 and GATA6. A) Oligonucleotides GATA-B (top left) and GATA-A (bottom left) incubated with granulosa cell nuclear extracts from each RNAi condition treated with vehicle or 8Br-cAMP. The labels C, G6, G4, and G4þG6 are as defined in Figure 1 . Numbers under each lane represent the specific band intensity relative to the vehicle-treated control RNAi condition. Graphs on the right represent the quantification of specific band intensities from two to three separate experiments; upper and lower panels represent nuclear extracts from the same experiment. Asterisks and brackets indicate specific protein:DNA complexes, and ns represents nonspecific bands. B) Competition experiment (vehicle treatment shown) using 100-fold excess cold self and GATA consensus oligo (GATA-2X). Upper and lower panels represent nuclear extracts from the same experiment. C) Supershift EMSA using control and GATA6 RNAi conditioned nuclear extracts and normal goat (gt) IgG or antibodies for GATA6 and GATA4. Note that the GATA6 antibody shows primarily reduced complexes. Treatment for 2 h is shown in all panels. ss, position of supershifted bands.
